Skip to main content
. 2016 Jun 30;9:3975–3983. doi: 10.2147/OTT.S103112

Table 2.

Correlations of TGF-β1 and CD163 expressions with clinicopathologic characteristics of gastric cancer patients

Variable n TGF-β1
CD163
High Low P-value High Low P-value
Sex 0.738 0.623
 Male 125 79 46 68 57
 Female 53 32 21 26 27
Age (years) 0.536 0.548
 ≤60 94 61 33 42 42
 >60 84 50 34 52 42
Tumor size (cm) 0.015 0.020
 <3 44 22 22 17 27
 3–5 54 30 24 26 28
 >5 80 59 21 51 29
Borrmann 0.032 0.029
 I 22 11 11 10 12
 II 55 32 23 21 34
 III 62 36 26 38 24
 IV 39 32 7 25 14
Differentiation <0.001 <0.001
 High 12 3 9 3 9
 Moderate 57 24 33 20 37
 Poor 109 84 25 71 38
Depth of invasion 0.033 0.002
 T1 16 5 11 5 11
 T2 18 10 8 3 15
 T3 67 47 20 39 28
 T4 77 49 28 47 30
Lymph node metastasis <0.001 <0.001
 N0 49 18 31 13 36
 N1 36 17 19 13 23
 N2 35 26 9 11 13
 N3 58 50 8 46 12
Distant metastasis 0.003 0.019
 M0 138 78 60 66 72
 M1 40 33 7 28 12
TNM stage 0.002 <0.001
 I 21 8 13 5 16
 II 34 17 17 10 24
 III 83 53 30 51 32
 IV 40 33 7 28 12

Abbreviations: TGF, transforming growth factor; TNM, tumor node metastasis.